# Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery

> **NCT07013591** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Coronary Artery Bypass Graft

## Interventions

- **DRUG:** MIB-626
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07013591
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2028-10-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07013591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07013591, "Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07013591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*